Physician profile
Chase Ansok
NPI 1629496237
$30,110.06
in general payments reported to CMS, 2019-2025
12 companies · $2,680 in 2025
The $2,680 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,295 · 2021: $12K · 2022: $7,249 · 2023: $2,029 · 2024: $4,155 · 2025: $2,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,972 · Food and Beverage: $2,891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,972.27 |
| Food and Beverage | $2,891.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $15,303.10 | 2020-2025 | |
| Exactech, INC. | $9,407.81 | 2020-2025 | |
| Arthrex, INC. | $1,601.75 | 2021-2025 | |
| Medical Device Business Services, INC. | $1,569.80 | 2024 | Healix Knotless Peek |
| Stryker Corporation | $800.51 | 2021-2025 | Blueprint Patient Specific Instrumentation, Alphavent |
| Skeletal Dynamics INC | $756.70 | 2021 | |
| Depuy Synthes Sales INC. | $211.04 | 2024-2025 | Na, Dynacord, Healix Knotless Peek |
| Linvatec Corporation | $161.39 | 2021-2022 | |
| Si-Bone, INC. | $124.53 | 2025 | |
| Smith+Nephew, INC. | $93.48 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Zimmer Biomet Holdings, INC. | $60.90 | 2022 | |
| Fx Shoulder Solutions, INC | $19.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Ansok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.